In fact, they report that 5% of their "effectively treated" patients had sudden death. Of even more concern is the consideration that of all of their cases of sudden death, 83% occurred on treatment, and only 17% occurred on no treatment! In addition to the socioeconomic disadvantages of P-blockade for life, there is a possibility that the treatment might be dangerous to some patients with long QT syndrome, particularly those with sinus or atrioventricular nodal disorders; Moss et a17 found that bradycardia was one of the most important risk factors for the syndrome. In the present study, bradycardia was present on routine ECG in 20% of all subjects, and with treadmill testing, 36% had maximal heart rates below normal. An additional 5% of their patients had secondor third-degree atrioventricular block. Questions occur, then, as to whether binodal disease is a significant part of the long QT syndrome and whether P-blockade, particularly with large doses of propranolol, might worsen the chances of having syncope Finally, we probably all can agree that long QT syndrome, taken as a whole, is a serious disease at any age and that treatment is, at best, only partly effective. Let us hope for further elucidation of the basic mechanism and a more specific and effective treatment. In the meantime, "first, do no harm" seems particularly pertinent for this disorder.
